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Dietary deep seawater and hepatic steatosisFatty liver disease is a growing health concern in western
and other developed countries. The cause of fatty liver can be
broken down into two categories: (1) alcoholic fatty liver
disease and (2) nonalcoholic fatty liver disease (NAFLD). The
abnormal retention of fat as vacuole in hepatocytes is more
commonly known as steatosis and can progress further to
steatohepatitis, possibly resulting in hepatocytic damage.
According to the latest practice guidelines for the diagnosis
and management of NAFLD,1 a patient with NAFLD typically
has histological or imaging evidence of hepatic steatosis, with
no history of significant alcohol consumption or steatogenic
drug use. NAFLD is often linked with risk factors such as
obesity, diabetes mellitus, and dyslipidemia. Worldwide, its
estimated prevalence ranges from 6.3% to 33%, with a median
of 20% in the general population.
Hepatic steatosis is an important change that is related to
chronic inflammation of the liver. It has been reported that
alcohol intake stimulates the production of proinflammatory
cytokine interleukin-12 (IL-12), leading to an increased serum
level of IL-12 in patients with alcoholic liver disease. How-
ever, the IL-12 level in the hepatic steatosis group was similar
to that in the control group after the patients stopped using
alcohol for 9 months, suggesting that hepatic steatosis is
reversible.2 By contrast, it was reported that 52% of Chinese
patients with chronic hepatitis C had hepatic steatosis. This
correlation is observed frequently in patients with chronic
hepatitis C virus infection3 and also presents an increased risk
factor for the development of hepatocellular carcinoma.4
Recently, it was reported that mice lacking miR-122a
(Mir122a) might develop steatohepatitis, fibrosis, and hep-
atocellular carcinoma. Steatosis was the result of an impaired
expression of microsomal triglyceride transfer protein.5
However, the detailed mechanism underlying the develop-
ment for hepatic steatosis in relation to changes in intracellular
signaling pathways and extracellular microenvironment still
requires further investigation.
Eicosanoids are lipid signaling molecules that play impor-
tant roles in the regulation of inflammation in the body. The
eicosanoids derived from omega-6 (n-6) polyunsaturated fatty
acids (n-6 PUFA) and omega-3 PUFA (n-3 PUFA) are proin-
flammatory and anti-inflammatory functional molecules,
respectively. The ratio of n-6 PUFA to n-3 PUFA has increased
significantly in recent years, which has corresponded well with
the observed increases in obesity, cardiovascular disease, and1726-4901/$ - see front matter Copyright  2013 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2013.01.013NAFLD.6 Consequently, in order to maximize patient benefits,
it is important for clinicians to also treat the associated met-
abolic syndrome customarily seen in NAFLD patients, such as
obesity and hyperlipidemia. Increased exercise, combined
with reduced caloric intake, can result in weight loss and
reduced hepatic steatosis.1
In the February 2013 issue of the Journal of the Chinese
Medical Association, Chen et al7 examined the effects of deep
seawater drinking water on high-fat-diet-induced oxidation
and lipid accumulation in hepatocytes of hamsters. Their
results clearly showed that hamsters that consumed
300e1500 ppm deep seawater drinking water, undergoing a 6-
week high-fat diet, had reduced serum cholesterol and trigly-
ceride levels significantly, in a dose-dependent manner. In
addition, cholesterol and triglyceride levels in the liver were
also decreased significantly, along with an increase in the
levels of fecal bile acid, cholesterol, and triglyceride in a dose-
dependent manner. These results suggest that drinking deep
seawater may have decreased the uptake of cholesterol and
butter in the high-fat diet and/or increased the excretion of
triglyceride and cholesterol through bile and feces. Moreover,
similar results were found by these authors using the same
model of hamsters fed on a high-fat/high-cholesterol diet,
reaching the conclusion that 300e1500 ppm deep seawater
drinking water has a cardiovascular protective effect.8 It is
interesting that when rabbits that had been fed a high-fat diet
and drinking 28, 300, or 1200 ppm desalinated deep seawater
reverted back to their normal diet, the decrease in total cho-
lesterol and low-density lipoprotein cholesterol levels was
higher than that of the control rabbits.9 Furthermore, Lee
et al10 used deep ocean water to culture red mold dioscorea
(RMD) and compared its hypolipidemic effect to that of the
reverse osmosis water-cultured RMD in hyperlipidemic ham-
sters. It was found that deep-ocean-water-cultured RMD had a
higher level of magnesium (Mg2þ) ion because of its mineral
richness, and displayed a greater effect on lowering cholesterol
levels and lipid peroxidation in serum. These in vivo results
together suggest that the reduction of hyperlipidemic effect by
drinking deep seawater is closely related to the high levels of
mineral ions such as Mg2þ, and may have resulted more from
an increased excretion of steroids in the feces than from the
inhibition of uptake of dietary fat.
Several studies have examined whether cardiovascular
disease mortality is, in any way, related to dietary waterhinese Medical Association. All rights reserved.
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levels in drinking water of 10,094 cases of Taiwan residents
with acute myocardial infarction as well as of 10,094 matched
control without acute myocardial infarction. Based on the data
from the Taiwan Water Supply Corporation on Ca and Mg2þ
levels in drinking water throughout Taiwan, it was found that
higher Ca level, but not Mg2þ level, in drinking water had a
significant protective effect on the risk of death from acute
myocardial infarction. A recent study further examined the
effect of drinking deep seawater with high levels of Mg2þ
(Mg: 395 mg/L, hardness 1410 ppm) on blood lipids and its
antioxidant capacity in 42 hypercholesterolemic volunteers. It
was found that drinking 1050 mL deep seawater per day for
6 weeks resulted in a time-dependent decrease in blood cho-
lesterol levels and serum low-density lipoprotein cholesterol.
Moreover, drinking deep seawater also lowered serum lipid
peroxidation in these hypercholesterolemic individuals.12
These results clearly indicate that mineral ions in the drink-
ing water are important components in the proper maintenance
and regulation of lipid metabolism. Drinking water or deep
seawater with high levels of Ca and/or Mg2þ ions appears to
beneficially attenuate the serum cholesterol and low-density
lipoprotein cholesterol levels in individuals with acute myo-
cardial infarction and hypercholesterolemia. The detailed
mechanism of this correlation and its potential long-term side
effects merit further investigation.References
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